drugset / Trial / NCT00159770
Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
Evaluation of the antipsychotic efficacy and safety of ziprasidone versus olanzapine, risperidone or quetiapine in patients with schizophrenia, schizoaffective and schizophreniform disorders under naturalistic conditions of clinical practice
Timeline
- Start
- 2001-11
- Primary completion
- —
- Completion
- 2004-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Olanzapine | Small molecule | 10 mg | — |
| Subject | Olanzapine | Small molecule | 20 mg | — |
| Subject | Quetiapine | Small molecule | 300 mg | — |
| Subject | Quetiapine | Small molecule | 750 mg | — |
| Subject | Risperidone | Other / unclassified | 4 mg | — |
| Subject | Risperidone | Other / unclassified | 8 mg | — |
| Subject | Ziprasidone | Small molecule | 80 mg | — |
| Subject | Ziprasidone | Small molecule | 160 mg | — |